ENvue Medical Inc. (FEED) - Total Assets
Based on the latest financial reports, ENvue Medical Inc. (FEED) holds total assets worth $38.41 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ENvue Medical Inc. operating cash flow efficiency for how efficiently the company converts equity into cash flow.
ENvue Medical Inc. - Total Assets Trend (2011–2025)
This chart illustrates how ENvue Medical Inc.'s total assets have evolved over time, based on quarterly financial data. See FEED share price today for real-time trading data and today's change.
ENvue Medical Inc. - Asset Composition Analysis
Current Asset Composition (December 2025)
ENvue Medical Inc.'s total assets of $38.41 Million consist of 17.7% current assets and 82.3% non-current assets. Explore ENvue Medical Inc. (FEED) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 10.3% |
| Accounts Receivable | $543.00K | 1.3% |
| Inventory | $2.34 Million | 5.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $4.38 Million | 10.7% |
| Goodwill | $29.08 Million | 70.7% |
Asset Composition Trend (2011–2025)
This chart illustrates how ENvue Medical Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ENvue Medical Inc.'s current assets represent 17.7% of total assets in 2025, a decrease from 86.9% in 2011.
- Cash Position: Cash and equivalents constituted 10.3% of total assets in 2025, down from 82.3% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 80.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 70.7% of total assets.
ENvue Medical Inc. Competitors by Total Assets
Key competitors of ENvue Medical Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
MicroPort Endovascular MedTech Ltd
SHG:688016
|
China | CN¥4.96 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
DRTECH Corporation
KQ:214680
|
Korea | ₩235.84 Billion |
ENvue Medical Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.66 | 1.05 | 16.84 |
| Quick Ratio | 0.31 | 0.72 | 16.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-2.49 Million | $349.00K | $6.19 Million |
ENvue Medical Inc. - Advanced Valuation Insights
This section examines the relationship between ENvue Medical Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.13 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 1033.2% |
| Total Assets | $41.12 Million |
| Market Capitalization | $369.49K USD |
Valuation Analysis
Below Book Valuation: The market values ENvue Medical Inc.'s assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: ENvue Medical Inc.'s assets grew by 1033.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for ENvue Medical Inc. (2011–2025)
The table below shows the annual total assets of ENvue Medical Inc. from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $41.12 Million | +1033.20% |
| 2024-12-31 | $3.63 Million | -45.62% |
| 2023-12-31 | $6.67 Million | +13.52% |
| 2022-12-31 | $5.88 Million | -31.81% |
| 2021-12-31 | $8.62 Million | +4.78% |
| 2020-12-31 | $8.23 Million | +304.17% |
| 2019-12-31 | $2.04 Million | +28.86% |
| 2018-12-31 | $1.58 Million | -67.52% |
| 2017-12-31 | $4.87 Million | +884.82% |
| 2016-12-31 | $494.00K | -75.09% |
| 2015-12-31 | $1.98 Million | +174.27% |
| 2014-12-31 | $723.00K | +4.63% |
| 2013-12-31 | $691.00K | +97.99% |
| 2012-12-31 | $349.00K | -67.83% |
| 2011-12-31 | $1.08 Million | -- |
About ENvue Medical Inc.
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, incre… Read more